Clinuvel Pharmaceuticals Limited (ASX:CUV – Get Rating) insider Philippe Wolgen purchased 1,000 shares of the business’s stock in a transaction on Tuesday, May 10th. The stock was acquired at an average price of A$16.14 ($11.21) per share, with a total value of A$16,143.00 ($11,210.42). Philippe Wolgen also recently made the following trade(s): On Tuesday, March […]